Back
Rocket Pharmaceuticals Stock Price Chart
Trump's Tariffs Are Reshaping Markets
Grade any 3 stocks FREE to see if your portfolio is at risk.
Sell
7
RCKT
Rocket Pharmaceuticals
Last Price:
$2.78
Seasonality Move:
3.46%
7 Day Trial
ALL ACCESS PASS
$
7
Here's the Best Day to Buy Nvidia
Click here to see the green days for 5 major stocks today.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RCKT is experiencing selling pressure, which indicates risk of future bearish movement.
Rocket Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.11 | Sell |
| 20-day SMA: | 5.25 | Sell |
| 50-day SMA: | 6.09 | Sell |
| 200-day SMA: | 12.18 | Sell |
| 8-day EMA: | 3.41 | Sell |
| 20-day EMA: | 4.7 | Sell |
| 50-day EMA: | 6.17 | Sell |
| 200-day EMA: | 11.46 | Sell |
Rocket Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.15 | Sell |
| Relative Strength Index (14 RSI): | 29.89 | Sell |
| Chaikin Money Flow: | -2917287 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.74 - 7.66) | Sell |
| Bollinger Bands (100): | (5.67 - 10.39) | Sell |
Rocket Pharmaceuticals Technical Analysis
| May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 21 | 22 | 23 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Rocket Pharmaceuticals Stock
Is Rocket Pharmaceuticals Stock a Buy?
-
Rocket Pharmaceuticals share price is 2.92 while RCKT 8-day simple moving average is 3.11, which is a Sell signal.
-
The stock price of RCKT is 2.92 while Rocket Pharmaceuticals 20-day SMA is 5.25, which makes it a Sell.
-
Rocket Pharmaceuticals 50-day simple moving average is 6.09 while RCKT share price is 2.92, making it a Sell technically.
-
RCKT stock price is 2.92 and Rocket Pharmaceuticals 200-day simple moving average is 12.18, creating a Sell signal.
RCKT Technical Analysis vs Fundamental Analysis
Sell
7
Rocket Pharmaceuticals (RCKT)
is a Sell
Is Rocket Pharmaceuticals a Buy or a Sell?
-
Rocket Pharmaceuticals stock is rated a SellThe current Rocket Pharmaceuticals [RCKT] share price is $2.92. The Score for RCKT is 7, which is 86% below its historic median score of 50, and infers higher risk than normal.
Rocket Pharmaceuticals Stock Info
Market Cap:
314.6M
Price in USD:
2.92
Share Volume:
4.6M
Rocket Pharmaceuticals 52-Week Range
52-Week High:
26.98
52-Week Low:
2.19
Sell
7
Rocket Pharmaceuticals (RCKT)
is a Sell
Rocket Pharmaceuticals Share Price Forecast
-
What is the Rocket Pharmaceuticals stock price today?The Rocket Pharmaceuticals stock price is 2.92 USD today.
-
Will RCKT stock go up or go down?Rocket Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Rocket Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Rocket Pharmaceuticals is overvalued.
Is Rocket Pharmaceuticals Stock a Buy?
-
Rocket Pharmaceuticals share price is 2.92 while RCKT 8-day exponential moving average is 3.41, which is a Sell signal.
-
The stock price of RCKT is 2.92 while Rocket Pharmaceuticals 20-day EMA is 4.70, which makes it a Sell.
-
Rocket Pharmaceuticals 50-day exponential moving average is 6.17 while RCKT share price is 2.92, making it a Sell technically.
-
RCKT stock price is 2.92 and Rocket Pharmaceuticals 200-day simple moving average is 11.46, creating a Sell signal.
Fundamental Analysis of Rocket Pharmaceuticals
Is Rocket Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.22 per share, an increase next quarter of $0.17 per share, an increase this year of $0.68 per share, and an increase next year of $0.67 per share.
Technical Analysis of Rocket Pharmaceuticals
Should I short Rocket Pharmaceuticals stock?
-
RCKT Moving Average Covergence Divergence (MACD) indicator is -1.15, suggesting Rocket Pharmaceuticals is a Sell
-
Rocket Pharmaceuticals Relative Strength Index (RSI) is 29.89, which suggest Rocket Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Rocket Pharmaceuticals is (3.74 - 7.66), which suggest Rocket Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Rocket Pharmaceuticals is (5.67 - 10.39), which suggest Rocket Pharmaceuticals is a Sell
* Rocket Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.